EP-2006 Dosimetric benefit of the first clinical SBRT of lymph node oligometastases on the 1.5T MR-linac. (April 2019) - Winkel, D.; Bol, G.H.; Werensteijn-Honingh, A.M.; Intven, M.P.W.; Eppinga, W.S.C.; Van Asselen, B.; Hes, J.; Raaymakers, B.W.; Jürgenliemk-Schulz, I.M.; Kroon, P.S.